Black Diamond Therapeutics, Inc. (BDTX): SCHEDULE 13G/A filed Feb 14, 2025

Name: Black Diamond Therapeutics, Inc. SCHEDULE 13G/A (0001104659-25-013934)
Creator: Black Diamond Therapeutics, Inc.
Published: 2025-02-14

Form type: SCHEDULE 13G/A
Filing date: Feb 14, 2025
Accession number: 0001104659-25-013934
Filer: Black Diamond Therapeutics, Inc. (CIK 1701541)